Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study

Hip osteoarthritis (HOA) leads to pain and reduced function. The use of intra-articular injections based on corticosteroids, platelet-rich plasma (PRP), or hyaluronic acid (HA) is becoming a common symptomatic therapy for HOA. For the first time, we compare the effectiveness of plasma with a high co...

Full description

Bibliographic Details
Main Authors: Michelangelo Palco, Paolo Rizzo, Giorgio Carmelo Basile, Angelo Alito, Daniele Bruschetta, Maria Accorinti, Roberto Restuccia, Danilo Leonetti
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/7/4/222
_version_ 1797504374321184768
author Michelangelo Palco
Paolo Rizzo
Giorgio Carmelo Basile
Angelo Alito
Daniele Bruschetta
Maria Accorinti
Roberto Restuccia
Danilo Leonetti
author_facet Michelangelo Palco
Paolo Rizzo
Giorgio Carmelo Basile
Angelo Alito
Daniele Bruschetta
Maria Accorinti
Roberto Restuccia
Danilo Leonetti
author_sort Michelangelo Palco
collection DOAJ
description Hip osteoarthritis (HOA) leads to pain and reduced function. The use of intra-articular injections based on corticosteroids, platelet-rich plasma (PRP), or hyaluronic acid (HA) is becoming a common symptomatic therapy for HOA. For the first time, we compare the effectiveness of plasma with a high concentration of platelets and leukocytes (L-PRP) with PRP+HA in patients with mild to moderate HOA. A total of 26 patients in each group were administered with either L-PRP or PRP+HA. Outcomes were evaluated at baseline, 3 months, and 1 year after the injection. The mean visual analog scale (VAS) and Harris hip score (HHS) within and between groups among different time points were compared using repeated measures ANCOVA (age set as a covariate). Both treatments were effective in reducing VAS, but not in significantly increasing HHS. In the group treated with L-PRP, VAS showed interaction between time and treatment (in favor of L-PRP). Pairwise comparison for treatment and time point evidenced a significant difference at 1-year follow-up between L-PRP and PRP-HA. Outcomes support the idea that both treatments may be effective in reducing pain, with maximal pain reduction achieved after 3 months. L-PRP showed better results in reducing VAS over time. Both treatments are effective at reducing pain in the short to medium term. L-PRP could be the treatment of choice due to a more marked effect over time. Nevertheless, further research is needed to better describe the clinical outcome of these formulations.
first_indexed 2024-03-10T04:03:43Z
format Article
id doaj.art-d2b9d85f06f04227867f8977ff1f8ea2
institution Directory Open Access Journal
issn 2310-2861
language English
last_indexed 2024-03-10T04:03:43Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj.art-d2b9d85f06f04227867f8977ff1f8ea22023-11-23T08:28:11ZengMDPI AGGels2310-28612021-11-017422210.3390/gels7040222Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective StudyMichelangelo Palco0Paolo Rizzo1Giorgio Carmelo Basile2Angelo Alito3Daniele Bruschetta4Maria Accorinti5Roberto Restuccia6Danilo Leonetti7Department of Biomedical, Dental and Morphological and Functional Images, Section of Orthopedics and Traumatology, University of Messina, 98122 Messina, ItalyDepartment of Biomedical, Dental and Morphological and Functional Images, Section of Orthopedics and Traumatology, University of Messina, 98122 Messina, ItalyDepartment of Biomedical, Dental and Morphological and Functional Images, University of Messina, 98122 Messina, ItalyComplex Operating Unit of Physical and Rehabilitation Medicine and Sports Medicine, Policlinico Universitario G. Martino, 98124 Messina, ItalyDepartment of Biomedical, Dental and Morphological and Functional Images, University of Messina, 98122 Messina, ItalyComplex Operating Unit of Physical and Rehabilitation Medicine and Sports Medicine, Policlinico Universitario G. Martino, 98124 Messina, ItalyComplex Operating Unit of Physical and Rehabilitation Medicine and Sports Medicine, Policlinico Universitario G. Martino, 98124 Messina, ItalyDepartment of Biomedical, Dental and Morphological and Functional Images, Section of Orthopedics and Traumatology, University of Messina, 98122 Messina, ItalyHip osteoarthritis (HOA) leads to pain and reduced function. The use of intra-articular injections based on corticosteroids, platelet-rich plasma (PRP), or hyaluronic acid (HA) is becoming a common symptomatic therapy for HOA. For the first time, we compare the effectiveness of plasma with a high concentration of platelets and leukocytes (L-PRP) with PRP+HA in patients with mild to moderate HOA. A total of 26 patients in each group were administered with either L-PRP or PRP+HA. Outcomes were evaluated at baseline, 3 months, and 1 year after the injection. The mean visual analog scale (VAS) and Harris hip score (HHS) within and between groups among different time points were compared using repeated measures ANCOVA (age set as a covariate). Both treatments were effective in reducing VAS, but not in significantly increasing HHS. In the group treated with L-PRP, VAS showed interaction between time and treatment (in favor of L-PRP). Pairwise comparison for treatment and time point evidenced a significant difference at 1-year follow-up between L-PRP and PRP-HA. Outcomes support the idea that both treatments may be effective in reducing pain, with maximal pain reduction achieved after 3 months. L-PRP showed better results in reducing VAS over time. Both treatments are effective at reducing pain in the short to medium term. L-PRP could be the treatment of choice due to a more marked effect over time. Nevertheless, further research is needed to better describe the clinical outcome of these formulations.https://www.mdpi.com/2310-2861/7/4/222PRPosteoarthritiscartilagedegenerationpaingel
spellingShingle Michelangelo Palco
Paolo Rizzo
Giorgio Carmelo Basile
Angelo Alito
Daniele Bruschetta
Maria Accorinti
Roberto Restuccia
Danilo Leonetti
Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study
Gels
PRP
osteoarthritis
cartilage
degeneration
pain
gel
title Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study
title_full Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study
title_fullStr Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study
title_full_unstemmed Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study
title_short Short- and Midterm Comparison of Platelet-Rich Plasma with Hyaluronic Acid versus Leucocyte and Platelet-Rich Plasma on Pain and Function to Treat Hip Osteoarthritis. A Retrospective Study
title_sort short and midterm comparison of platelet rich plasma with hyaluronic acid versus leucocyte and platelet rich plasma on pain and function to treat hip osteoarthritis a retrospective study
topic PRP
osteoarthritis
cartilage
degeneration
pain
gel
url https://www.mdpi.com/2310-2861/7/4/222
work_keys_str_mv AT michelangelopalco shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT paolorizzo shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT giorgiocarmelobasile shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT angeloalito shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT danielebruschetta shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT mariaaccorinti shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT robertorestuccia shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy
AT daniloleonetti shortandmidtermcomparisonofplateletrichplasmawithhyaluronicacidversusleucocyteandplateletrichplasmaonpainandfunctiontotreathiposteoarthritisaretrospectivestudy